IDEX Corporation Acquires Isolation Technologies in a Strategic
Expansion of Its Health and Science Technologies Segment

NORTHBROOK, Ill.--(BUSINESS WIRE)--Oct 18, 2007 - IDEX Corporation
(NYSE: IEX) today announced the acquisition of Isolation
Technologies, a leading developer of advanced column hardware and
accessories for the High Performance Liquid Chromatography (HPLC)
market. HPLC instruments are used in a variety of analytical
chemistry applications, with primary commercial applications
including drug discovery and quality control measurements for
pharmaceutical and food/beverage testing.

Headquartered in Hopedale, MA, Isolation Technologies has annual
revenues of approximately $11 million. Isolation Technologies will
be operated as part of the company's Sapphire Engineering business
within IDEX's Health and Science Technologies segment. The cash
consideration was just under $30 million and is expected to be
accretive to IDEX's earnings in 2008.

IDEX Corporation is an applied solutions company specializing in
fluid and metering technologies, health and science technologies,
dispensing equipment, and fire, safety and other diversified
products built to its customers' exacting specifications. Its
products are sold in niche markets to a wide range of industries
throughout the world. IDEX shares are traded on the New York Stock
Exchange and Chicago Stock Exchange under the symbol "IEX".

For further information on IDEX Corporation and its business
units, visit the company's Web site at www.idexcorp.com.